Last $22.81 USD
Change Today -0.14 / -0.61%
Volume 1.5M
AEGR On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - aegerion pharmaceuticals inc (AEGR)

Name (Connections)Board RelationshipsTitleKey Developments
Anne VanLent 65 RelationshipsDirector and Chairman of Audit Committee 
Paul Thomas 31 RelationshipsDirector and Member of Audit Committee 
Sandford Smith 61 RelationshipsDirector and Member of Audit Committee 

Compensation Committee* - aegerion pharmaceuticals inc (AEGR)

Name (Connections)Board RelationshipsTitle
Sol Barer Ph.D. 175 RelationshipsDirector, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
David Scheer 43 RelationshipsChairman, Member of Nominating & Corporate Governance Committee and Member of Compensation Committee
AEGR Compensation vs. Industry
584.2K
361.4K
Chief Executive Officer
350.0K
266.2K
Chief Financial Officer
340.0K
345.6K
Chief Operating Officer
Share price activity for AEGERION PHARMACEUTICALS INC (AEGR)
52 Week Price Performance
AEGR
Industry Average

Nominating Committee* - aegerion pharmaceuticals inc (AEGR)

Name (Connections)Board RelationshipsTitleKey Developments
David Scheer 43 RelationshipsChairman, Member of Nominating & Corporate Governance Committee and Member of Compensation CommitteeAegerion Pharmaceuticals, Inc. Appoints Fraser as COO, Effective August 1, 2014
10/17/14
Antonio Gotto Jr., M.D., D.Phil. 95 RelationshipsDirector and Chairman of Nominating & Corporate Governance CommitteeAegerion Pharmaceuticals Announces Officer Appointments
07/30/14
Sol Barer Ph.D. 175 RelationshipsDirector, Chairman of Compensation Committee and Member of Nominating & Corporate Governance CommitteeAegerion Pharmaceuticals, Inc. Appoints Anne M. VanLent to Board of Directors
04/29/13

Corporate Governance Committee* - aegerion pharmaceuticals inc (AEGR)

Name (Connections)Board RelationshipsTitle
Sol Barer Ph.D. 175 RelationshipsDirector, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
Antonio Gotto Jr., M.D., D.Phil. 95 RelationshipsChairman, Member of Nominating & Corporate Governance Committee and Member of Compensation Committee
David Scheer 43 Relationships--
AEGR and Competitor
Insiders vs. External
Board
7%
93%
Aegerion Pharmaceuticals, Inc.
Insiders
External Board Members

Advisory Committee* - aegerion pharmaceuticals inc (AEGR)

Name (Board Relationships)/Title Board Affiliations
David Cohen 13 Relationships
Member of Scientific Advisory Board
No other board affiliations
Jay Horton 13 Relationships
Member of Scientific Advisory Board
No other board affiliations
Johannes Kastelein 89 Relationships
Chairman of European Scientific Advisory Board
No other board affiliations
Willis Maddrey 162 Relationships
Member of Scientific Advisory Board
No other board affiliations
James McKenney 13 Relationships
Member Scientific Advisory Board
No other board affiliations
Daniel Rader 60 Relationships
Member of Scientific Advisory Board
No other board affiliations
Frank Sacks 13 Relationships
Member of Scientific Advisory Board
No other board affiliations
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AEGR:US $22.81 USD -0.14

AEGR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for AEGR.
View Industry Companies
 

Industry Analysis

AEGR

Industry Average

Valuation AEGR Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 5.0x
Price/Book 4.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AEGERION PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.